Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D04XWX
|
||||
Former ID |
DIB003581
|
||||
Drug Name |
PS-178990
|
||||
Synonyms |
SARMs (muscle wasting disease), BMS; SARMs (muscle wasting disease), Ligand; SARMs (muscle wasting disease), Pharmacopeia; Selective androgen receptor modulators (muscle wasting disease), BMS; Selective androgen receptor modulators (muscle wasting disease), Ligand; Selective androgen receptor modulators (muscle wasting disease), Pharmacopeia
|
||||
Indication | Muscle atrophy [ICD10:M62.5] | Phase 1 | [548632] | ||
Company |
Bristol-Myers Squibb Co
|
||||
Target and Pathway | |||||
Target(s) | Androgen receptor | Target Info | Binder | [544063] | |
Pathway Interaction Database | Regulation of nuclear SMAD2/3 signaling | ||||
Coregulation of Androgen receptor activity | |||||
Regulation of Androgen receptor activity | |||||
Nongenotropic Androgen signaling | |||||
Regulation of nuclear beta catenin signaling and target gene transcription | |||||
FOXA1 transcription factor network | |||||
Notch-mediated HES/HEY network | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.